These results suggest that loss of K18 expression in ERα-positive breast cells, and failure of cytoplasmic sequestration of the ERα coactivator LRP16, may contribute to tumor proliferation by increasing ERα signaling in the nucleus. Here, KRT18 is linked to neoplasm.